Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 2.231.411.201.520.90

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 2.23 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52
Mar20200.90

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52
68.89
Mar2020 0.9 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹39,503.8 Cr -6.8% -12% 57.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,303.0 Cr -5.1% -9.4% 29.2% Stock Analytics
DIVIS LABORATORIES ₹143,389.0 Cr -7.3% -10.9% 53% Stock Analytics
CIPLA ₹114,645.0 Cr -1.4% -6.7% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹98,449.5 Cr -9% -14.4% 1.4% Stock Analytics
ZYDUS LIFESCIENCES ₹91,587.4 Cr -7% -5% 22.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-6.8%

-12%

57.4%

SENSEX

0.1%

-3.6%

7.9%


You may also like the below Video Courses